Oncology & Cancer

Scientists design protein that prods cancer-fighting T-cells

Scientists at UW Medicine's Institute for Protein Design (IPD) in Seattle have created a new protein that mimics the action of a key immune regulatory protein, interleukin 2 (IL-2).  IL-2 is a potent anticancer drug and ...

Diseases, Conditions, Syndromes

Kidney stones tied to increased renal cell carcinoma risk

(HealthDay)—Kidney stones are associated with an increased risk for renal cell carcinoma (RCC), specifically papillary RCC, and upper tract urothelial carcinoma (UTUC), according to a study published online Dec. 19 in the ...

Oncology & Cancer

New cancer immunotherapy drugs rapidly reach patients after approval

The majority of patients eligible for cancer immunotherapy drugs known as checkpoint inhibitors received treatment within a few months of FDA approval, according to a new Yale-led study. The finding suggests that cancer immunotherapies ...

Oncology & Cancer

Use of ibuprofen and similar NSAIDs may shorten life of patients

Ibuprofen, aspirin, and other non-steroidal anti-inflammatory medications are among the most commonly utilized medications in the United States. Primarily for treating pain, inflammation, and preventing cardiovascular disease, ...

page 2 from 14